Search results
Sep 20, 2024 · Alan Sandler, MD is an accomplished leader in oncology and drug development, with experience leading clinical development and operations, regulatory affairs, drug safety and asset development strategy across industry and academia.
Dec 1, 2020 · Dr. Sandler brings nearly 30 years of oncology and drug development experience across industry and academia. During his tenure at Genentech /Roche, he led the teams responsible for the global development and regulatory approval of several innovative medicines, most recently Tecentriq®.
Dec 1, 2020 · Dr. Sandler was most recently the Senior Vice President and Global Head of Product Development Oncology at Genentech, a member of the Roche Group. He will report to Dr. Samantha Du, Chief Executive Officer, and serve on the executive team.
Mar 4, 2024 · Elevation Oncology, Inc. announced the appointments of Julie Cherrington, Ph.D. and Alan Sandler, M.D., to its Board of Directors.
Nov 8, 2022 · Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, announced the appointment of Alan Sandler, M.D., to the position of executive vice president and chief medical officer.
Mar 4, 2024 · Dr. Sandler is an accomplished leader in oncology and drug development, with experience leading clinical development and operations, regulatory affairs, drug safety and asset development strategy...
AlanSandlerMD. Hematology • South San Francisco, CA. Professor of Medicine, Oregon Health & Sci University. Office. 1 DNA Drive. South San Francisco, CA 94080. Phone+1 650-477-6605. Is this information wrong? Education & Training. Yale-New Haven Medical Center Fellowship, Hematology and Medical Oncology, 1989 - 1992.
